US 9,808,488 B2
Isolated populations of renal stem cells and methods of isolating and using same
Benjamin Dekel, Tel-Aviv (IL); and Orit Harari-Steinberg, RaAnana (IL)
Assigned to Tel HaShomer Medical Research Infrastructure and Services Ltd., Ramat-Gan (IL)
Filed by Tel HaShomer Medical Research Infrastructure and Services Ltd., Ramat-Gan (IL)
Filed on Sep. 8, 2014, as Appl. No. 14/479,385.
Application 14/479,385 is a division of application No. 13/203,282, granted, now 8,828,722, previously published as PCT/IL2010/000158, filed on Feb. 25, 2010.
Claims priority of provisional application 61/202,425, filed on Feb. 26, 2009.
Claims priority of provisional application 61/202,426, filed on Feb. 26, 2009.
Prior Publication US 2015/0139963 A1, May 21, 2015
Int. Cl. A61K 35/12 (2015.01); A61K 35/22 (2015.01); C12N 5/071 (2010.01); C12N 5/074 (2010.01); C12N 15/85 (2006.01)
CPC A61K 35/22 (2013.01) [C12N 5/0686 (2013.01); C12N 5/0687 (2013.01); C12N 5/0696 (2013.01); C12N 15/85 (2013.01); C12N 2500/90 (2013.01); C12N 2501/06 (2013.01); C12N 2501/065 (2013.01); C12N 2501/415 (2013.01); C12N 2506/25 (2013.01)] 9 Claims
 
1. A method of treating a renal damage in a subject in need thereof comprising administering to the subject a therapeutically effective amount of renal cells comprising at least 50% cells having a NCAM+ signature, thereby treating the renal damage in the subject.